In human patients with soft tissue sarcomas, loss of CDKN2B and CDKN2A is associated with reduced survival [27], while in dogs, absence or reduced levels of p16INK4A have been reported in melanoma tumours and cell lines [28], as well as in osteosarcoma cell lines [29]. Here, CDKN2B is linked to soft tissue sarcoma.